Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Evidence-Based Deprescribing of Statins in Patients With Advanced Illness

Evidence-Based Deprescribing of Statins in Patients With Advanced Illness Research Original Investigation Discontinuing Statins in Terminally Ill Patients medications in older adults: addressing 21. Abernethy AP, Aziz NM, Basch E, et al. National Institute of Nursing Research State of the polypharmacy. Arch Intern Med. 2010;170(18): A strategy to advance the evidence base in Science Conference; August 11, 2011; Bethesda, MD. 1648-1654. palliative medicine: formation of a palliative care 32. Ridker PM, Wilson PW. A trial-based approach research cooperative group. J Palliat Med.2010;13 9. Miller GE, Stagnitti MN. Trends in Statin Use in to statin guidelines. JAMA. 2013;310(11):1123-1124. (12):1407-1413. the Civilian Noninstitutionalized Medicare 33. Kjekshus J, Apetrei E, Barrios V, et al; CORONA Population, 1997 and 2002. Washington, DC: Agency 22. O’Brien PC, Fleming TR. A multiple testing Group. Rosuvastatin in older patients with systolic for Healthcare Research and Quality; September procedure for clinical trials. Biometrics. 1979;35(3): heart failure. N Engl J Med. 2007;357(22):2248-2261. 2005. 549-556. 34. Wanner C, Krane V, März W, et al; German 10. LaRosa JC, He J, Vupputuri S. Effect of statins 23. D’Hoore W, Sicotte C, Tilquin C. Risk Diabetes and Dialysis Study Investigators. on risk of coronary disease: a meta-analysis of adjustment in outcome assessment: the Charlson Atorvastatin in patients with type 2 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Evidence-Based Deprescribing of Statins in Patients With Advanced Illness

JAMA Internal Medicine , Volume 175 (5) – May 1, 2015

Loading next page...
 
/lp/american-medical-association/evidence-based-deprescribing-of-statins-in-patients-with-advanced-rMW9SCZhIn
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2015.0328
pmid
25799203
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Discontinuing Statins in Terminally Ill Patients medications in older adults: addressing 21. Abernethy AP, Aziz NM, Basch E, et al. National Institute of Nursing Research State of the polypharmacy. Arch Intern Med. 2010;170(18): A strategy to advance the evidence base in Science Conference; August 11, 2011; Bethesda, MD. 1648-1654. palliative medicine: formation of a palliative care 32. Ridker PM, Wilson PW. A trial-based approach research cooperative group. J Palliat Med.2010;13 9. Miller GE, Stagnitti MN. Trends in Statin Use in to statin guidelines. JAMA. 2013;310(11):1123-1124. (12):1407-1413. the Civilian Noninstitutionalized Medicare 33. Kjekshus J, Apetrei E, Barrios V, et al; CORONA Population, 1997 and 2002. Washington, DC: Agency 22. O’Brien PC, Fleming TR. A multiple testing Group. Rosuvastatin in older patients with systolic for Healthcare Research and Quality; September procedure for clinical trials. Biometrics. 1979;35(3): heart failure. N Engl J Med. 2007;357(22):2248-2261. 2005. 549-556. 34. Wanner C, Krane V, März W, et al; German 10. LaRosa JC, He J, Vupputuri S. Effect of statins 23. D’Hoore W, Sicotte C, Tilquin C. Risk Diabetes and Dialysis Study Investigators. on risk of coronary disease: a meta-analysis of adjustment in outcome assessment: the Charlson Atorvastatin in patients with type 2

Journal

JAMA Internal MedicineAmerican Medical Association

Published: May 1, 2015

References